WO2025163520 - ENT1 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES WITH INCREASED ADENOSINE LEVELS
National phase entry is expected:
Publication Number
WO/2025/163520
Publication Date
07.08.2025
International Application No.
PCT/IB2025/050979
International Filing Date
29.01.2025
Title **
[English]
ENT1 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES WITH INCREASED ADENOSINE LEVELS
[French]
INHIBITEURS ENT1 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES AYANT DES NIVEAUX D'ADÉNOSINE ACCRUS
Applicants **
ITEOS BELGIUM SA
Inventors
MARILLIER, Reece Gerrad
SHEHADE, Hussein
ROSSETTI, Maura
ROSEWICK, Nicolas
MCGRATH, Yvonne
HOUTHUYS, Erica Joke Kateligne Heleen
MARTINOLI, Chiara
STROZZI, Francesco
DEKONINCK, Sophie
POON, Edmund
Priority Data
63/626,747
30.01.2024
US
63/730,101
10.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5876 | |
| EPO | Filing, Examination, Granting | 123363 | |
| Japan | Filing, Examination, Granting | 4948 | |
| South Korea | Filing, Examination, Granting | 8692 | |
| USA | Filing, Examination, Granting | 58390 |
Total:
201,269
Contact Us
Abstract[English]
The present disclosure relates to identifying subjects with increased adenosine and treatment of a subject who has been identified with an increased adenosine.[French]
La présente divulgation concerne l'identification de sujets présentant une adénosine accrue et le traitement d'un sujet qui a été identifié avec une adénosine accrue.